Ilie SM, Briot N, Constantin G, Roussot N, et al. Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy. Breast Cancer 2023 Aug 10. doi: 10.1007/s12282-023-01490.
PMID: 37561255